Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Jul 05, 2016 $14.72 $14.72 $14.72 $14.72 59 200
Jul 01, 2016 $14.97 $14.97 $14.97 $14.97 151 700
Jun 30, 2016 $14.13 $14.13 $14.13 $14.13 65 100
Jun 29, 2016 $14.24 $14.24 $14.24 $14.24 165 000
Jun 28, 2016 $13.43 $13.43 $13.43 $13.43 57 400
Jun 27, 2016 $12.96 $12.96 $12.96 $12.96 110 800
Jun 24, 2016 $13.64 $13.64 $13.64 $13.64 552 400
Jun 23, 2016 $14.33 $14.33 $14.33 $14.33 157 600
Jun 22, 2016 $14.10 $14.10 $14.10 $14.10 237 600
Jun 21, 2016 $14.35 $14.35 $14.35 $14.35 69 200
Jun 20, 2016 $14.62 $14.62 $14.62 $14.62 89 700
Jun 17, 2016 $14.43 $14.43 $14.43 $14.43 152 500
Jun 16, 2016 $15.57 $15.57 $15.57 $15.57 61 874
Jun 15, 2016 $15.68 $15.68 $15.68 $15.68 81 292
Jun 14, 2016 $15.23 $15.23 $15.23 $15.23 71 111
Jun 13, 2016 $15.47 $15.47 $15.47 $15.47 98 947
Jun 10, 2016 $15.49 $15.49 $15.49 $15.49 40 531
Jun 09, 2016 $16.00 $16.00 $16.00 $16.00 143 895
Jun 08, 2016 $16.08 $16.08 $16.08 $16.08 107 471
Jun 07, 2016 $16.61 $16.61 $16.61 $16.61 120 132
Jun 06, 2016 $17.05 $17.05 $17.05 $17.05 78 870
Jun 03, 2016 $16.95 $16.95 $16.95 $16.95 117 249
Jun 02, 2016 $17.38 $17.38 $17.38 $17.38 139 230
Jun 01, 2016 $16.62 $16.62 $16.62 $16.62 85 796
May 31, 2016 $17.20 $17.20 $17.20 $17.20 62 258
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT